Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Часто задаваемые вопросы
В каком секторе работает Quantum-Si incorporated (QSIAW)?
Quantum-Si incorporated относится к сектору Здравоохранение.
Какова текущая цена акций Quantum-Si incorporated (QSIAW)?
По последним данным, цена акций Quantum-Si incorporated составляет 0,01 $, предыдущее закрытие — 0,01 $.
Выплачивает ли Quantum-Si incorporated (QSIAW) дивиденды?
Нет, Quantum-Si incorporated не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Quantum-Si incorporated (QSIAW)?
У компании Quantum-Si incorporated бета 2.990, что свидетельствует о крайне высокой волатильности по сравнению с рынком